Ivor MacLeod
Financieel Directeur/CFO bij SCYNEXIS, INC.
Vermogen: 235 495 $ op 30-04-2024
Actieve functies van Ivor MacLeod
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SCYNEXIS, INC. | Comptroller/Controller/Auditor | 24-10-2022 | - |
| Financieel Directeur/CFO | 24-10-2022 | - | |
| Public Communications Contact | 24-10-2022 | - |
Loopbaan van Ivor MacLeod
Eerdere bekende functies van Ivor MacLeod
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ATHERSYS, INC. | Comptroller/Controller/Auditor | 19-05-2021 | 30-06-2022 |
| Financieel Directeur/CFO | 31-01-2020 | 30-06-2022 | |
| MERCK & CO., INC. | Financieel Directeur/CFO | - | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Compliance Officer | 01-06-2015 | - |
| Financieel Directeur/CFO | 01-06-2015 | - | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Hoofd Techniek/Wetenschap/O&O | - | 05-04-2011 |
| Financieel Directeur/CFO | 05-04-2011 | - | |
| Corporate Officer/Principal | - | - |
Opleiding van Ivor MacLeod
| Eller College of Management | Masters Business Admin |
| University of St. Andrews | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director of Finance/CFO | 5 |
| Comptroller/Controller/Auditor | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ATHERSYS, INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Beurs
- Insiders
- Ivor MacLeod
- Ervaring
